Modification of radiosensitivity following chemotherapy exposure: potential implications for combined-modality therapy.
Britten
Richard A
RA
Department of Radiation Oncology, Eastern Virginia Medical School, Norfolk, Virginia, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
D011838:Radiation-Sensitizing Agents